Targeting viral induced TSLP - an airway treatment opportunity

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Obstructive Lung Disease 100%
• Antivirus Agent 100%
• Beta Interferon 100%
• Capsazepine 50%
• Inflammation 24%
• Glucocorticoid 24%

Immunology and Microbiology

• Viral Disease 50%
• Phosphorylation 50%
• Adaptive Immune System 24%
• Epithelium 24%
• Innate Immune System 24%
• Inflammation 24%
• Respiratory Mucosa 24%
• Severe Asthma 24%
• Glucocorticoid 24%
• Interferon 24%